200 related articles for article (PubMed ID: 16612645)
21. [When is aftercare useful in renal cell cancer?].
Ebert T; Fischer C
Urologe A; 2005 Sep; 44(9):1018, 1020-3. PubMed ID: 16047197
[TBL] [Abstract][Full Text] [Related]
22. [Pain and symptom management in palliative care].
Gaertner J; Voltz R; Golla H; Ostgathe C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Nov; 49(11):1097-103. PubMed ID: 17072512
[TBL] [Abstract][Full Text] [Related]
23. [Therapy of malignant melanoma. First-, second- and pathogenesis-oriented third-line therapies].
Rass K; Tadler D; Tilgen W
Hautarzt; 2006 Sep; 57(9):773-84. PubMed ID: 16924435
[TBL] [Abstract][Full Text] [Related]
24. [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].
Heidenreich A; Krege S; Flasshove M
Urologe A; 2004 Dec; 43(12):1521-30. PubMed ID: 15592709
[TBL] [Abstract][Full Text] [Related]
25. [Palliative therapy concepts for patients with urothelial cancer of the urinary bladder].
Vom Dorp F; Börgermann C; Rübben H
Urologe A; 2007 Jan; 46(1):54-5. PubMed ID: 17203266
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of testicular cancer: from palliation to curative adjuvant therapy.
Jacobs EM; Muggia FM; Rozencweig M
Semin Oncol; 1979 Mar; 6(1):3-13. PubMed ID: 88071
[No Abstract] [Full Text] [Related]
27. Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.
Einhorn LH
Cancer Res; 1981 Sep; 41(9 Pt 1):3275-80. PubMed ID: 6167346
[TBL] [Abstract][Full Text] [Related]
28. [Aftercare or not--that is the question!].
Schubert-Fritschle G; Weissbach L; Hölzel D
Urologe A; 2005 Sep; 44(9):991-6. PubMed ID: 16049723
[TBL] [Abstract][Full Text] [Related]
29. [Options in palliative therapy for penile cancer].
Preis E; Jakse G
Urologe A; 2007 Jan; 46(1):49-53. PubMed ID: 17203267
[TBL] [Abstract][Full Text] [Related]
30. [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].
Heine K; Wolff JM
Urologe A; 2005 Sep; 44(9):1009-12, 1014-7. PubMed ID: 16096743
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy at end-of-life: an integration of oncology and palliative team.
Chan WL; Lam KO; Siu WK; Yuen KK
Support Care Cancer; 2016 Mar; 24(3):1421-7. PubMed ID: 26604192
[TBL] [Abstract][Full Text] [Related]
32. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
33. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
Grünberger B; Raderer M; Schmidinger M; Hejna M
Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
[TBL] [Abstract][Full Text] [Related]
34. Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.
Rørth M; von der Maase H; Sandberg Nielsen E; Schultz HP; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):295-304. PubMed ID: 6208750
[TBL] [Abstract][Full Text] [Related]
35. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
[TBL] [Abstract][Full Text] [Related]
36. The curability of breast cancer and the treatment of advanced disease.
Guarneri V; Conte PF
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
[TBL] [Abstract][Full Text] [Related]
37. [Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Langenkamp S; Albers P
Urologe A; 2007 Oct; 46(10):1389-90, 1392-4. PubMed ID: 17874229
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of patients with testicular germ cell cancer.
Hartmann JT; Kanz L; Bokemeyer C
Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
[TBL] [Abstract][Full Text] [Related]
39. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutical options for seminomas at clinical stage I-IIA/B].
Heidenreich A
Urologe A; 2004 Nov; 43(11):1435-44; quiz 1445. PubMed ID: 15526184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
